EUVIMEDEUVIMED entdecken
Querschnittstudie

Lipid profile and liver enzyme alterations in HIV-positive patients receiving highly active antiretroviral therapy in South-Eastern Nigeria: A cross-sectional analysis and implications for pharmacogenetic research

Francis O Ugwuene, Blessing U Onwumelu, Innocent O Orhonigbe, Amaechi L Ogara, Linus Ogbonnaya Agwu, Isioma Christian Okonta, Bravo Udochukwu Umeh, Parker Elijah Joshua

Environmental Toxicology and Pharmacology · 2026-12 · 128 · 105196

DOI: 10.1016/j.etap.2026.105196 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Environmental Toxicology and Pharmacology, 2026-12. Verfasst von Francis O Ugwuene und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, Faculty of Allied Health Sciences, College of Medicine, Enugu State University of Science & Technology (ESU…. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Highly active antiretroviral therapy (HAART) improves survival in HIV infection but has been linked to metabolic and hepatic alterations that vary across populations. METHODS: This cross-sectional study compared serum lipid profile and liver enzyme activities between HIV-positive adults receiving HAART continuously for at least six months (n = 50) and HIV-negative controls (n = 50) in South-Eastern Nigeria, using independent-samples t-tests. RESULTS: Total cholesterol, LDL-C, and VLDL-C were significantly lower in the HAART group (p < 0.05). ALT was lower (p < 0.001) and AST was higher (p = 0.005) in the HAART group; triglycerides and HDL-C did not differ significantly between groups. CONCLUSION: HAART was associated with altered lipid and liver enzyme profiles in this population. The pattern differs from reports in predominantly European-ancestry cohorts. Nutritional, regimen-related, and host genetic factors are all plausible contributors; the genetic explanation remains speculative in the absence of pharmacogenetic testing. Routine biochemical monitoring and dedicated pharmacogenomic studies in African populations are warranted.

Schlagwörter

Stichwörter der Autor:innen

HAARTHIVLipid profileLiver enzymesNigeriaPharmacogenetics

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, Faculty of Allied Health Sciences, College of Medicine, Enugu State University of Science & Technology (ESUT), Enugu State, Nigeria.
  • Department of Biochemistry, Delta State University, Abraka, Delta State, Nigeria.
  • Department of Science Laboratory Technology, University of Nigeria, Nsukka, Nigeria.
  • Department of Biochemistry, Federal University of Technology, Owerri, Imo State, Nigeria.
  • Department of Medical Biochemistry, University of Delta, Agbor, Delta State, Nigeria.
  • Department of Genetics and Biotechnology, University of Nigeria, Nsukka, Nigeria. Electronic address: bravo.umeh@unn.edu.ng.

Zitieren

APA

Ugwuene, F. O., Onwumelu, B. U., Orhonigbe, I. O., Ogara, A. L., Agwu, L. O., Okonta, I. C., Umeh, B. U., & Joshua, P. E. (2026). Lipid profile and liver enzyme alterations in HIV-positive patients receiving highly active antiretroviral therapy in South-Eastern Nigeria: A cross-sectional analysis and implications for pharmacogenetic research. Environmental Toxicology and Pharmacology, 128, 105196. https://doi.org/10.1016/j.etap.2026.105196

Vancouver

Ugwuene FO, Onwumelu BU, Orhonigbe IO, Ogara AL, Agwu LO, Okonta IC, et al. Lipid profile and liver enzyme alterations in HIV-positive patients receiving highly active antiretroviral therapy in South-Eastern Nigeria: A cross-sectional analysis and implications for pharmacogenetic research. Environmental Toxicology and Pharmacology. 2026;128:105196. doi:10.1016/j.etap.2026.105196

BibTeX
@article{Ugwuene2026,
  author = {Ugwuene, Francis O and Onwumelu, Blessing U and Orhonigbe, Innocent O and Ogara, Amaechi L and Agwu, Linus Ogbonnaya and Okonta, Isioma Christian and Umeh, Bravo Udochukwu and Joshua, Parker Elijah},
  title = {Lipid profile and liver enzyme alterations in HIV-positive patients receiving highly active antiretroviral therapy in South-Eastern Nigeria: A cross-sectional analysis and implications for pharmacogenetic research},
  journal = {Environmental Toxicology and Pharmacology},
  year = {2026},
  volume = {128},
  pages = {105196},
  doi = {10.1016/j.etap.2026.105196}
}
Kostenlos starten →